bioAffinity Technologies, Inc. (BIAF)

NASDAQ: BIAF · Real-Time Price · USD

2.720

+0.510 (23.08%)

Apr 28, 2026, 2:54 PM EDT - Market open

bioAffinity Technologies Employees

bioAffinity Technologies had 57 employees as of December 31, 2025. The number of employees did not change compared to the previous year.

Employees

57

Change (1Y)

n/a

Growth (1Y)

n/a

Revenue / Employee

$108,105

Profits / Employee

-$261,575

Market Cap

12.22M

Employees Chart

Employees History

Date	Employees	Change	Growth
Dec 31, 2025	57	0	-
Dec 31, 2024	57	-18	-24.00%
Dec 31, 2023	75	61	435.71%
Dec 31, 2022	14	3	27.27%
Dec 31, 2021	11	-	-

Related Stocks

Company Name	Employees
Inotiv	2,046
MDxHealth	364
Biodesix	334
XWELL	280
Exagen	220
Precipio	71
Advanced Biomed	31
Mainz Biomed	26

Employee Rankings

BIAF News

5 hours ago - bioAffinity Technologies Launches New Study To Expand Use of CyPath® Lung Technology for Asthma and COPD Diagnosis and Treatment - Business Wire
14 days ago - New Case Study: bioAffinity Technologies' CyPath® Lung Diagnostic Supports Physician's Assessment, Prompts Follow-Up Imaging and Defers Unnecessary Biopsy - Business Wire
19 days ago - bioAffinity Technologies Transcript: Status update - Transcripts
21 days ago - bioAffinity Technologies' CyPath® Lung to Be Featured at Cleveland Clinic Annual “Advances in Early Lung Cancer Detection” Symposium April 16 - Business Wire
27 days ago - bioAffinity Technologies' CyPath® Lung Test Unit Sales Surged 146% Year-Over-Year in Q1 2026 - Business Wire
4 weeks ago - bioAffinity Technologies to Host Live Virtual Physician Roundtable on Integrating CyPath® Lung into Pulmonary Practice - Business Wire
6 weeks ago - New Case Study: bioAffinity Technologies' CyPath® Lung Provides Actionable Results and Helps Patient Avoid Costly, Invasive Procedures - Business Wire
6 weeks ago - bioAffinity Technologies Stock Soars 120% On CyPath Lung Sales Growth - Benzinga